𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rapid determination of enzyme activities of recombinant human cytochromes P450, human liver microsomes and hepatocytes

✍ Scribed by Anima Ghosal; Neil Hapangama; Yuan Yuan; Xiaowen Lu; Debra Horne; James E. Patrick; Shmuel Zbaida


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
94 KB
Volume
24
Category
Article
ISSN
0142-2782

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Cytochrome P450 (CYP) substrates that yield fluorescent metabolites were used for rapid screening of drug metabolism activities of 13 recombinant human cytochromes P450, human liver microsomes and human hepatocytes. Reproducible results were obtained using a fluorescent plate reader (CytoFluor) more expediently than those generated using conventional HPLC methods. Typically, results for 96 samples were obtained with the plate reader in less than 10 min as opposed to 15–35 min/sample required by conventional HPLC. The fluorescent substrates used to measure CYP activities were as follows: 3‐cyano‐7‐ethoxycoumarin (CEC) for CYP1A1, CYP1A2, CYP2C9 and CYP2C19; 7‐ethoxyresorufin (7‐ER) for CYP1A1, CYP1A2 and CYP1B1; 3‐[2‐(N,N‐diethyl‐N‐methylammonium)ethyl]‐7‐methoxy‐4‐methylcoumarin (AMMC) for CYP2D6; dibenzylfluorescein (DBF) for CYP3A4, CYP3A5 and CYP2C8; 7‐methoxy‐4‐trifluoromethylcoumarin (7‐MFC) for CYP2E1, CYP2B6 and CYP2C18; and coumarin for CYP2A6. The chemical inhibition and correlation data indicated that the following substrates can be used as specific functional probes for individual cytochrome P450 present in human liver microsomes: coumarin for CYP2A6 (r=0.82), AMMC for CYP2D6 (r=0.83) and DBF for CYP3A4 (r=0.92). The fluorescent plate reader was found to be useful for the rapid assessment of CYP activities (positive control) in both intact cells and subcellular fractions. Copyright © 2003 John Wiley & Sons, Ltd.


📜 SIMILAR VOLUMES


Expression and regulation of cytochrome
✍ Edward L. LeCluyse; Ajay Madan; Geraldine Hamilton; Kathy Carroll; Ryan DeHaan; 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 339 KB 👁 1 views

The aim of this study was to test suitable culture conditions for maintaining normal cellular cytoarchitecture and inducibility of P450 enzymes in primary cultures of human hepatocytes by prototypical inducers. The selectivity and sensitivity of a sandwich culture system were determined by treating

Recombinant Production of Human Microsom
✍ Matthias Dietrich; Lisa Grundmann; Katja Kurr; Laura Valinotto; Tanja Saussele; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB

## Abstract __Microsomal cytochrome P450 monooxygenases of groups 1–3 are mainly expressed in the liver and play a crucial role in phase 1 reactions of xenobiotic metabolism. The cDNAs encoding human CYP2D6 and human NADPH‐P450 oxidoreductase (CPR) were transformed into the methylotrophic yeast__ P

Metabolism of thalidomide in human micro
✍ Steve K. Teo; P. J. Sabourin; K. O'Brien; K. A. Kook; S. D. Thomas 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 117 KB 👁 1 views

Previous in vitro studies in rat microsomal preparations suggested that thalidomide is metabolized by the cytochrome P450 system (CYP). In this study, we examined the extent of thalidomide metabolism by preparations of pooled human microsomes, microsomes containing cloned human CYP isozymes (CYP1A2,

A quantitative comparison of dibenzo[a,l
✍ Leon C. King; Linda Adams; Joycelyn Allison; Michael J. Kohan; Garret Nelson; Dh 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

Dibenzo [a,l]pyrene (DB[a,l]P), an extremely potent environmental carcinogen, is metabolically activated in mammalian cells and microsomes through the fjord-region dihydrodiol, trans-DB[a,l]P-11,12-diol, to synand anti-DB[a,l]P-11,12-diol-13,14-epoxides (syn-and anti-DB[a,l]PDEs). The role of seven

Equally potent inhibitors of cholesterol
✍ L.H. Cohen; R.E.W. van Leeuwen; G.C.F. van Thiel; J.F. van Pelt; S.H. Yap 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 433 KB 👁 1 views

Six 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (the present cholesterol-lowering drugs known as statins), lovastatin (L), simvastatin (S), pravastatin (P), fluvastatin (F), atorvastatin (A) and cerivastatin (C) are shown to be potent inhibitors of cholesterol synthesis in h